Highly multidrug-resistant Morganella morganii clinical isolates from Nepal co-producing NDM-type metallo-β-lactamases and the 16S rRNA methylase ArmA. Issue 4 (25th February 2020)

• Record Type: Journal Article
• Authors: Shrestha, Shovita; Tada, Tatsuya; Sherchan, Jatan B.; Uchida, Hiroki; Hishinuma, Tomomi; Oshiro, Satoshi; Morioka, Shinichiro; Kattel, Hari; Kirikae, Teruo; Sherchand, Jeevan B.
• Is Part Of: Journal of medical microbiology. Volume 69:Issue 4(2020)
• Page Start: 572
• Page End: 575
• Publication Date: 2020-02-25
• Subjects: multidrug resistance -- Morganella morganii -- NDM -- ArmA; Medical microbiology -- Periodicals; 616.9041
• DOI: 10.1099/jmm.0.001160
• Languages: English
• ISSNs: 0022-2615

Abstract

Abstract : Morganella morganii can harbour extended-spectrum β-lactamases and carbapenemases, resulting in increased resistance to multiple antibiotics and a high mortality rate. This study describes the emergence of highly multidrug-resistant clinical isolates of M. morganii from Nepal co-producing NDM-type metallo-β-lactamases, including NDM-1 and NDM-5, and the 16S rRNA methylase ArmA. This is the first report of M. morganii clinical isolates from Nepal co-producing NDM-1/-5 and ArmA. It is important to establish infection control systems and effective treatments against multidrug-resistant M. morganii .